# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Clinical Trials company in Sweden with the highest EBIT is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 506.25 M.
The Clinical Trials company in Sweden with the lowest EBIT is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at USD -60.31 M.
The top 10 Clinical Trials companies in Sweden by EBIT are Swedish Orphan Biovitrum AB (publ), Elekta AB (publ), Arjo AB (publ), Vitrolife AB (publ), Vimian Group AB (publ), Camurus AB (publ), RaySearch Laboratories AB (publ), Xvivo Perfusion AB (publ), CellaVision AB (publ) and Surgical Science Sweden AB (publ).
The bottom 10 Clinical Trials companies in Sweden by EBIT are Hansa Biopharma AB (publ), BioInvent International AB (publ), Moberg Pharma AB (publ), Egetis Therapeutics AB (publ), Oncopeptides AB (publ), Xspray Pharma AB (publ), Boule Diagnostics AB (publ), Alligator Bioscience AB (publ), BioArctic AB (publ) and Vicore Pharma Holding AB (publ).